Niagen Bioscience, Inc. (NASDAQ:NAGE) Given Consensus Rating of “Buy” by Brokerages

Shares of Niagen Bioscience, Inc. (NASDAQ:NAGE – Get Free Report) have been assigned an average recommendation of “Buy” from the five research firms that are presently covering the company, Marketbeat Ratings reports. Five equities research analysts have rate…